3 results
Primary:* To assess the safety and tolerability of LAM-001 administered daily by dry powder inhaler (DPI) for 14 days in patients with lymphangioleiomyomatosis (LAM) (Period 1).* To assess the longer-term safety and tolerability of LAM-001…
The purpose of this research study is to learn about the safety and effectiveness of 177Lu-PNT2002, an investigational agent being studied for patients with mCRPC who have experienced disease progression following treatment with abiraterone,…
Primary objective:• To assess the clinical safety and effectiveness of Pulse Rate (PR) and Respiration Rate (RR) measuredwith the VSC-MEDlib within the intended use compared to the gold-standard reference devices.Exploratory objective:• To assess…